Smileyscope

Smileyscope is a multi-award winning digital therapeutics company focused on improving needle experiences through innovative virtual reality technology. Their proprietary technology reframes medical procedures using choreographed virtual-reality (VR) experiences to reduce patient pain and anxiety, and enhance the overall patient experience. Approved by regulatory bodies for medical use, Smileyscope VR is clinically proven to decrease patient pain, anxiety, and the need for restraints during procedures such as needle procedures, wound dressings, and anaesthetic induction. Developed by clinicians for clinicians, Smileyscope VR seamlessly integrates into clinical workflows and has garnered strong support from medical professionals, patients, and caregivers. With operations spanning across Australia, USA, UAE, Europe, and the UK, Smileyscope VR is already being used in leading hospitals in several countries. The company's most recent achievement is the completion of a Seed Round investment on 03 October 2023, with investment from prominent backers including TEN13, Breakthrough Victoria, Med Angels, and LaunchVic. This financial backing is a testament to the potential of Smileyscope's technology in revolutionizing patient-centered care and improving medical experiences. For inquiries outside the USA, they can be reached at [email protected], while USA-based queries should contact [email protected] for further information.